Sidney Scudder

Prospective Evaluation of Cancer Clinical Trial Accrual Patterns: Identifying Potential Barriers to Enrollment

Primo N. Lara, Roger Higdon, Nelson Lim et al. · Journal of Clinical Oncology · 2001 · 601 citations

Phase II Clinical Trial of Bevacizumab and Low-Dose Metronomic Oral Cyclophosphamide in Recurrent Ovarian Cancer: A Trial of the California, Chicago, and Princess Margaret Hospital Phase II Consortia

Agustin A. García, Hal W. Hirte, Gini F. Fleming et al. · Journal of Clinical Oncology · 2007 · 547 citations

Polymorphisms and Clinical Outcome in Recurrent Ovarian Cancer Treated with Cyclophosphamide and Bevacizumab

Anne M. Schultheis, Georg Lurje, Katrin E. Rhodes et al. · Clinical Cancer Research · 2008 · 184 citations · Full text

STUDIES ON THE CHEMOTHERAPY OF THE HUMAN MALARIAS. VI. THE PHYSIOLOGICAL DISPOSITION, ANTIMALARIAL ACTIVITY, AND TOXICITY OF SEVERAL DERIVATIVES OF 4-AMINOQUINOLINE 12

Robert W. Berliner, David P. Earle, John V. Taggart et al. · Journal of Clinical Investigation · 1948 · 181 citations · Full text

Antiparasitic Agent, Medicine, The Physiological Disposition +8

Increased incidence of symptomatic venous thrombosis in patients with cervical carcinoma treated with concurrent chemotherapy, radiation, and erythropoietin

Ted Wun, Lisa Y. Law, Danielle Harvey et al. · Cancer · 2003 · 142 citations